SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Molly B. Conroy, C. Kent Kwoh, Eswar Krishnan, Michael C. Nevitt, Robert Boudreau, Laura D. Carbone, Hepei Chen, Tamara B. Harris, Anne B. Newman, Bret H. Goodpaster, Muscle strength, mass, and quality in older men and women with knee osteoarthritis, Arthritis Care & Research, 2012, 64, 1
  2. You have free access to this content2
    V. E. Valkhoff, E. M. Soest, G. M. C. Masclee, S. Bie, G. Mazzaglia, M. Molokhia, E. J. Kuipers, M. C. J. M. Sturkenboom, Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617 400-patient study, Alimentary Pharmacology & Therapeutics, 2012, 36, 8
  3. 3
    Chris Metcalfe, Benedict W Wheeler, David Gunnell, Richard M Martin, International regulatory activity restricting COX-2 inhibitor use and deaths due to gastrointestinal haemorrhage and myocardial infarction, Pharmacoepidemiology and Drug Safety, 2010, 19, 8
  4. You have free access to this content4
    V. E. VALKHOFF, E. M. VAN SOEST, M. C. J. M. STURKENBOOM, E. J. KUIPERS, Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs), Alimentary Pharmacology & Therapeutics, 2010, 31, 11
  5. 5
    Richard D. Wilson, Analgesic Prescribing for Musculoskeletal Complaints in the Ambulatory Care Setting After the Introduction and Withdrawal of Cyclooxygenase-2 Inhibitors, Archives of Physical Medicine and Rehabilitation, 2009, 90, 7, 1147

    CrossRef

  6. 6
    James M. Scheiman, Balancing Risks and Benefits of Cyclooxygenase-2 Selective Nonsteroidal Anti-Inflammatory Drugs, Gastroenterology Clinics of North America, 2009, 38, 2, 305

    CrossRef

  7. 7
    Michiel W. van der Linden, Sabine Gaugris, Ernst J. Kuipers, Myrthe P. P. van Herk-Sukel, Bart J. F. van den Bemt, Shuvayu S. Sen, Ron M. C. Herings, COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors, Pharmacoepidemiology and Drug Safety, 2009, 18, 10
  8. 8
    Michiel W. Van der Linden, Sabine Gaugris, Ernst J. Kuipers, Bart J. F. Van den Bemt, Myrthe P. P. van Herk-Sukel, Ron M. C. Herings, Gastroprotection among new chronic users of non-steroidal anti-inflammatory drugs: a study of utilization and adherence in the Netherlands*, Current Medical Research and Opinion, 2009, 25, 1, 195

    CrossRef

  9. 9
    Sebastian Schneeweiss, Robert J. Glynn, Jerry Avorn, Muhammad Mamdani, Helen Mogun, Daniel H. Solomon, NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxib, Pharmacoepidemiology and Drug Safety, 2009, 18, 12
  10. 10
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2008, 17, 6
  11. 11
    Frank Andersohn, E. Garbe, Pharmakoepidemiologische Forschung mit Routinedaten des Gesundheitswesens, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2008, 51, 10, 1135

    CrossRef